Every NAD+ nasal spray plan through telos rx includes quarterly labs. This article explains why regular lab monitoring matters for a compounded protocol, what your provider is actually looking for, and how labs factor into any decision to continue or adjust your plan.
Quarterly labs give your provider objective data, not just your self-reported experience. They are included in your plan at no extra cost and inform whether your provider continues, adjusts, or pauses your protocol. Your provider decides based on the results.
Start your intake →Why quarterly labs are built into every plan
Compounded medications, including NAD+ nasal spray, are not FDA-approved commercial products with a long track record of standardized outcome data. That is precisely why ongoing monitoring matters more here than it might for a familiar, well-established medication.
Labs give your provider something more reliable than a general sense of how you feel. Subjective impressions are useful and worth reporting, but they can be influenced by countless factors unrelated to any specific protocol. Objective lab data helps your provider separate signal from noise when deciding how to proceed.
This is also why telos rx builds quarterly labs into every plan rather than treating them as an optional add-on. Ongoing oversight, not a one-time approval, is the model for how compounded protocols should be managed responsibly.
What your provider is actually monitoring
The specific labs ordered depend on your individual health history and what your provider determines is relevant for your protocol. Telos rx does not publish a universal panel that applies to every patient, because appropriate monitoring depends on your circumstances.
In general, quarterly labs exist to give your provider a periodic checkpoint on relevant markers related to your overall health and how your body may be responding over time. Your provider interprets these results in the context of your history, not as an isolated number to react to on its own.
If a specific value falls outside an expected range, your provider will discuss what that might mean and whether any change to your protocol is warranted. That conversation happens with you, not around you, and no decision is made without your provider explaining their reasoning.
Key takeaway: Quarterly labs are a built-in checkpoint, not a hurdle. They give your provider real data to weigh alongside your feedback before deciding whether to continue, adjust, or pause your protocol.
How labs connect to dose adjustments
Dose adjustments are included in your telos rx plan, and quarterly labs are often the trigger for that conversation. If your provider sees something in your results that suggests a different approach could serve you better, they will raise it directly rather than leaving you to guess.
You are never expected to interpret your own labs and adjust your protocol independently. That decision belongs to your provider, who has the training and the full context of your case to make it responsibly. Your role is to complete labs as scheduled and report anything relevant you notice in the meantime.
If your labs come back within expected ranges and you have no new concerns, your provider may simply continue your current plan without any change. A quiet quarterly check-in that confirms things are stable is a good outcome, not a wasted one.
Start your intake if you want to begin a protocol that includes this kind of structured, ongoing oversight from day one.
What happens if you skip a scheduled lab
Missing a scheduled lab is not the end of your protocol, but it does leave your provider with less information to work with. If you miss one, message your care team as soon as you realize, and they will help you reschedule.
Depending on how long the gap has been and your specific history, your provider may want to see updated labs before continuing your protocol. They cannot make an informed decision without current information. That is not a punitive step. It is the same standard of care applied consistently.
Consistent lab completion is one of the more straightforward things you can do to support your own care. It takes a small amount of coordination and directly feeds into decisions that affect your protocol going forward.
How to prepare for a quarterly lab draw
Preparation for your quarterly labs is usually straightforward. Your care team will tell you if any specific preparation, such as fasting beforehand, is required for the particular tests your provider has ordered for your case. Follow those instructions exactly, since inconsistent preparation can affect certain results.
Keep a simple log of anything notable you have experienced since your last check-in, even things that seem minor. Sleep changes, new medications, travel, or significant life stress can all be relevant context for your provider when interpreting your labs alongside your protocol. A brief note is often more useful in the moment than trying to recall details weeks later from memory.
If scheduling a lab draw is logistically difficult, message your care team rather than letting the appointment lapse silently. Telos rx aims to make this as convenient as reasonably possible, and your care team can help you find an option that works with your specific schedule and location.
Bring any concerns to that conversation as well. If you have noticed something you want addressed, your quarterly lab review is a natural point to raise it. Your provider will already be looking closely at your full case at that particular time.
The evidence behind lab-based monitoring for compounded peptides
Regular laboratory monitoring is a standard practice across medicine generally, not something unique to telos rx or to NAD+ specifically. It reflects a broader principle in clinical care: decisions grounded in objective measurement tend to be more reliable than decisions based on subjective impression alone.
For compounded medications with a thinner published research base, like NAD+ and other peptides telos rx offers, this principle matters even more. Early research and proposed mechanisms describe what might be happening, while your individual labs describe what is actually happening in your specific case.
For background on how NAD+ functions in cellular metabolism, which is part of what your provider considers when interpreting your case, see the NIH review of NAD+ and cellular aging. For an overview of how compounded medications are regulated, see the FDA overview of drug compounding.
None of this means every compounded protocol requires the same intensity of monitoring as a novel prescription drug in a clinical trial setting. It means the monitoring should be proportionate to what is actually known, and quarterly labs are a reasonable, evidence-informed cadence for a protocol like NAD+ nasal spray specifically.
Your provider is also watching closely for anything unexpected that might warrant more frequent monitoring in your specific case. If your history includes other relevant health conditions, your provider may recommend a somewhat different lab schedule tailored specifically to you rather than the general quarterly default.
What labs cannot tell you
It is worth being honest about the limits of lab monitoring as well. Labs are useful for tracking certain measurable markers, but they cannot capture everything relevant to how a protocol is going for you personally. Your own reporting still matters and complements what labs show.
Labs also cannot promise a specific outcome from your protocol. They are a monitoring tool, not a guarantee of any particular result. Their value lies in helping your provider make better-informed decisions over time, not in predicting exactly how you will respond to NAD+ nasal spray.
Combining objective labs with your own honest reporting gives your provider the fullest possible picture. Neither piece alone tells the whole story, which is exactly why telos rx builds both into every plan rather than relying on just one. Treat your quarterly check-in as a genuine two-way conversation rather than a formality to get through quickly.
How this fits into your broader plan
Quarterly labs sit alongside the other elements of your telos rx plan. Free two-day shipping, unlimited care team messaging, and the ability to cancel anytime with no fee round out the structure. None of these pieces work in isolation. Together they form a structure meant to keep a licensed provider genuinely involved in your care.
If you are also considering other telos rx protocols, such as sermorelin or BPC-157, know that each comes with its own quarterly lab schedule and its own provider-led monitoring. Combining protocols does not remove this oversight. It simply means more data points for your provider to review together.
Cost is also worth mentioning directly. NAD+ nasal spray is available as low as one hundred sixteen dollars a month, and quarterly labs are included in that price rather than billed separately. There is no hidden fee for the monitoring that keeps your plan grounded in real data.
If you have questions about how labs work at telos rx, or want to see the full structure of a protocol before committing, start your intake. You can ask your provider directly once your case has been reviewed.
Frequently Asked Questions
Are quarterly labs included in the cost of my plan?
Yes. Quarterly labs are included at no extra cost as part of your telos rx plan, alongside dose adjustments and unlimited care team messaging.
What if my labs come back outside the expected range?
Your provider will explain what the result may mean and discuss whether any change to your protocol makes sense. No decision is made without that conversation happening first.
Can I interpret my own labs and adjust my dose?
No. Adjusting your protocol is a decision made by your provider, who has the full context of your case. Report anything you notice, but let your provider make that call.
What happens if I miss a scheduled lab?
Message your care team to reschedule as soon as you can. Your provider may ask for updated labs before continuing your protocol if the gap has been significant.
Do all telos rx protocols include quarterly labs?
Yes. Quarterly labs are a standard part of every telos rx plan, including sermorelin, BPC-157, and PT-141, not just NAD+ nasal spray.
Why does telos rx emphasize monitoring for compounded peptides?
Compounded peptides generally have a thinner published research base than well-established prescription drugs. Ongoing lab-based monitoring helps ground decisions in your specific data rather than assumptions.
telos rx is LegitScript-certified. Compounded medication is not FDA-approved and is prepared by partner compounding pharmacies. This article is general information, not medical advice, and does not replace guidance from your own provider. Any protocol is subject to medical approval by a licensed provider, and approval is not guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service.
Want a protocol with real ongoing monitoring? Message the telos rx care team or start your evaluation at telos rx.